Annual EBIT
-$53.02 M
+$5.77 M+9.82%
December 31, 2023
Summary
- As of February 8, 2025, AXDX annual earnings before interest & taxes is -$53.02 million, with the most recent change of +$5.77 million (+9.82%) on December 31, 2023.
- During the last 3 years, AXDX annual EBIT has risen by +$9.63 million (+15.37%).
- AXDX annual EBIT is now -1459.62% below its all-time high of $3.90 million, reached on July 31, 1998.
Performance
AXDX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$11.05 M
-$2.05 M-22.75%
September 30, 2024
Summary
- As of February 8, 2025, AXDX quarterly earnings before interest & taxes is -$11.05 million, with the most recent change of -$2.05 million (-22.75%) on September 30, 2024.
- Over the past year, AXDX quarterly EBIT has stayed the same.
- AXDX quarterly EBIT is now -440.30% below its all-time high of $3.25 million, reached on September 30, 2023.
Performance
AXDX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$42.13 M
-$14.29 M-51.34%
September 30, 2024
Summary
- As of February 8, 2025, AXDX TTM earnings before interest & taxes is -$42.13 million, with the most recent change of -$14.29 million (-51.34%) on September 30, 2024.
- Over the past year, AXDX TTM EBIT has stayed the same.
- AXDX TTM EBIT is now -956.41% below its all-time high of $4.92 million, reached on April 30, 1998.
Performance
AXDX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AXDX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.8% | 0.0% | 0.0% |
| 3 y3 years | +15.4% | 0.0% | 0.0% |
| 5 y5 years | +32.0% | 0.0% | 0.0% |
AXDX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +14.6% | -440.3% | +63.9% | -51.3% | +43.4% |
| 5 y | 5-year | at high | +24.4% | -440.3% | +63.9% | -51.3% | +43.4% |
| alltime | all time | -1459.6% | +32.0% | -440.3% | +63.9% | -956.4% | +46.0% |
Accelerate Diagnostics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$11.05 M(+22.7%) | -$42.13 M(+51.3%) |
| Jun 2024 | - | -$9.00 M(-23.6%) | -$27.84 M(-43.7%) |
| Mar 2024 | - | -$11.78 M(+14.3%) | -$49.44 M(-6.8%) |
| Dec 2023 | -$53.02 M(-9.8%) | -$10.31 M(-417.5%) | -$53.02 M(-5.2%) |
| Sep 2023 | - | $3.25 M(-110.6%) | -$55.96 M(-24.8%) |
| Jun 2023 | - | -$30.60 M(+99.2%) | -$74.41 M(+20.8%) |
| Mar 2023 | - | -$15.36 M(+16.0%) | -$61.62 M(+4.8%) |
| Dec 2022 | -$58.80 M(-5.3%) | -$13.24 M(-12.9%) | -$58.80 M(-9.9%) |
| Sep 2022 | - | -$15.20 M(-14.7%) | -$65.25 M(+19.0%) |
| Jun 2022 | - | -$17.81 M(+41.9%) | -$54.82 M(+0.6%) |
| Mar 2022 | - | -$12.55 M(-36.3%) | -$54.51 M(-12.2%) |
| Dec 2021 | -$62.11 M(-0.9%) | -$19.69 M(+312.4%) | -$62.11 M(+8.4%) |
| Sep 2021 | - | -$4.78 M(-72.7%) | -$57.32 M(-14.9%) |
| Jun 2021 | - | -$17.50 M(-13.2%) | -$67.34 M(+3.2%) |
| Mar 2021 | - | -$20.15 M(+35.3%) | -$65.24 M(+4.1%) |
| Dec 2020 | -$62.65 M(-10.7%) | -$14.90 M(+0.6%) | -$62.65 M(-4.4%) |
| Sep 2020 | - | -$14.80 M(-3.9%) | -$65.53 M(-3.4%) |
| Jun 2020 | - | -$15.39 M(-12.3%) | -$67.81 M(-2.7%) |
| Mar 2020 | - | -$17.56 M(-1.2%) | -$69.68 M(-0.7%) |
| Dec 2019 | -$70.16 M(-10.1%) | -$17.77 M(+4.1%) | -$70.16 M(-1.7%) |
| Sep 2019 | - | -$17.07 M(-1.1%) | -$71.41 M(-2.1%) |
| Jun 2019 | - | -$17.27 M(-4.3%) | -$72.92 M(-3.5%) |
| Mar 2019 | - | -$18.04 M(-5.1%) | -$75.57 M(-3.1%) |
| Dec 2018 | -$78.00 M(+22.8%) | -$19.02 M(+2.3%) | -$78.00 M(+4.0%) |
| Sep 2018 | - | -$18.59 M(-6.7%) | -$75.00 M(+2.1%) |
| Jun 2018 | - | -$19.92 M(-2.7%) | -$73.44 M(+5.2%) |
| Mar 2018 | - | -$20.47 M(+27.8%) | -$69.80 M(+9.9%) |
| Dec 2017 | -$63.53 M(-3.9%) | -$16.02 M(-5.9%) | -$63.53 M(+0.2%) |
| Sep 2017 | - | -$17.03 M(+4.6%) | -$63.38 M(-0.4%) |
| Jun 2017 | - | -$16.28 M(+14.7%) | -$63.65 M(-2.4%) |
| Mar 2017 | - | -$14.20 M(-10.5%) | -$65.23 M(-1.5%) |
| Dec 2016 | -$66.11 M(+45.3%) | -$15.87 M(-8.3%) | -$66.20 M(+4.3%) |
| Sep 2016 | - | -$17.30 M(-3.2%) | -$63.50 M(+10.7%) |
| Jun 2016 | - | -$17.87 M(+17.8%) | -$57.38 M(+10.8%) |
| Mar 2016 | - | -$15.17 M(+15.3%) | -$51.77 M(+13.8%) |
| Dec 2015 | -$45.49 M(+47.1%) | -$13.16 M(+17.7%) | -$45.49 M(+12.1%) |
| Sep 2015 | - | -$11.19 M(-8.7%) | -$40.57 M(+6.2%) |
| Jun 2015 | - | -$12.25 M(+37.7%) | -$38.19 M(+12.0%) |
| Mar 2015 | - | -$8.90 M(+8.0%) | -$34.09 M(+10.2%) |
| Dec 2014 | -$30.93 M(+102.4%) | -$8.24 M(-6.5%) | -$30.93 M(+11.1%) |
| Sep 2014 | - | -$8.81 M(+8.1%) | -$27.85 M(+22.0%) |
| Jun 2014 | - | -$8.15 M(+42.2%) | -$22.83 M(+23.7%) |
| Mar 2014 | - | -$5.73 M(+11.1%) | -$18.46 M(+20.8%) |
| Dec 2013 | -$15.28 M(+349.5%) | -$5.16 M(+35.8%) | -$15.28 M(+50.9%) |
| Sep 2013 | - | -$3.80 M(+0.5%) | -$10.13 M(+32.0%) |
| Jun 2013 | - | -$3.78 M(+48.2%) | -$7.67 M(+26.5%) |
| Mar 2013 | - | -$2.55 M(+89.8%) | -$6.06 M(+42.1%) |
| Dec 2012 | -$3.40 M(+1.3%) | - | - |
| Oct 2012 | - | -$1.34 M(-38.1%) | -$4.27 M(+27.2%) |
| Jul 2012 | -$3.35 M(+470.6%) | -$2.17 M(+429.3%) | -$3.35 M(+129.5%) |
| Apr 2012 | - | -$410.20 K(+19.4%) | -$1.46 M(+23.3%) |
| Jan 2012 | - | -$343.60 K(-20.1%) | -$1.19 M(+33.3%) |
| Dec 2011 | -$588.00 K(+43.6%) | - | - |
| Oct 2011 | - | -$429.90 K(+54.7%) | -$889.20 K(+117.2%) |
| Jul 2011 | -$409.40 K(-166.9%) | -$277.90 K(+107.7%) | -$409.30 K(-124.3%) |
| Apr 2011 | - | -$133.80 K(+181.1%) | $1.68 M(+17.6%) |
| Jan 2011 | - | -$47.60 K(-195.2%) | $1.43 M(+31.8%) |
| Oct 2010 | - | $50.00 K(-97.2%) | $1.09 M(+77.4%) |
| Jul 2010 | $611.80 K | $1.81 M(-570.3%) | $611.70 K(-145.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2010 | - | -$385.50 K(-1.8%) | -$1.36 M(+13.3%) |
| Jan 2010 | - | -$392.40 K(-7.3%) | -$1.20 M(+29.8%) |
| Oct 2009 | - | -$423.40 K(+167.1%) | -$924.50 K(+36.1%) |
| Jul 2009 | -$679.10 K(-60.7%) | -$158.50 K(-29.8%) | -$679.10 K(-30.9%) |
| Apr 2009 | - | -$225.70 K(+93.1%) | -$982.50 K(-12.7%) |
| Jan 2009 | - | -$116.90 K(-34.3%) | -$1.13 M(-17.7%) |
| Oct 2008 | - | -$178.00 K(-61.5%) | -$1.37 M(-20.9%) |
| Jul 2008 | -$1.73 M(-18.3%) | -$461.90 K(+25.4%) | -$1.73 M(-1.0%) |
| Apr 2008 | - | -$368.30 K(+2.6%) | -$1.74 M(-8.0%) |
| Jan 2008 | - | -$358.90 K(-33.4%) | -$1.90 M(+82.4%) |
| Oct 2007 | - | -$538.50 K(+12.5%) | -$1.04 M(-7.0%) |
| Jul 2007 | -$2.11 M(-34.0%) | -$478.70 K(-8.0%) | -$1.12 M(-15.9%) |
| Apr 2007 | - | -$520.50 K(-204.5%) | -$1.33 M(-19.6%) |
| Jan 2007 | - | $498.00 K(-180.7%) | -$1.65 M(-44.9%) |
| Oct 2006 | - | -$617.30 K(-10.6%) | -$3.00 M(-6.3%) |
| Jul 2006 | -$3.20 M(+41.9%) | -$690.30 K(-18.2%) | -$3.20 M(-2.3%) |
| Apr 2006 | - | -$844.10 K(-0.7%) | -$3.28 M(+8.2%) |
| Jan 2006 | - | -$849.70 K(+3.7%) | -$3.03 M(+19.3%) |
| Oct 2005 | - | -$819.30 K(+6.8%) | -$2.54 M(+12.5%) |
| Jul 2005 | -$2.26 M(+27.4%) | -$767.20 K(+29.0%) | -$2.26 M(+19.8%) |
| Apr 2005 | - | -$594.50 K(+65.4%) | -$1.89 M(+11.5%) |
| Jan 2005 | - | -$359.50 K(-33.2%) | -$1.69 M(-6.4%) |
| Oct 2004 | - | -$537.90 K(+36.8%) | -$1.81 M(+2.4%) |
| Jul 2004 | -$1.77 M(-8.0%) | -$393.30 K(-1.7%) | -$1.76 M(-28.4%) |
| Apr 2004 | - | -$399.90 K(-15.7%) | -$2.46 M(+5.0%) |
| Jan 2004 | - | -$474.30 K(-4.1%) | -$2.34 M(+7.6%) |
| Oct 2003 | - | -$494.80 K(-54.6%) | -$2.18 M(+12.9%) |
| Jul 2003 | -$1.93 M(+150.6%) | -$1.09 M(+286.4%) | -$1.93 M(+95.5%) |
| Apr 2003 | - | -$282.30 K(-8.5%) | -$986.00 K(+17.0%) |
| Jan 2003 | - | -$308.40 K(+25.1%) | -$842.90 K(+12.5%) |
| Oct 2002 | - | -$246.50 K(+65.7%) | -$749.50 K(-2.6%) |
| Jul 2002 | -$769.30 K(-46.5%) | -$148.80 K(+6.9%) | -$769.30 K(-21.1%) |
| Apr 2002 | - | -$139.20 K(-35.3%) | -$974.60 K(-15.1%) |
| Jan 2002 | - | -$215.00 K(-19.3%) | -$1.15 M(-18.4%) |
| Oct 2001 | - | -$266.30 K(-24.8%) | -$1.41 M(-2.3%) |
| Jul 2001 | -$1.44 M(-37.9%) | -$354.10 K(+13.4%) | -$1.44 M(-20.9%) |
| Apr 2001 | - | -$312.20 K(-34.0%) | -$1.82 M(-24.3%) |
| Jan 2001 | - | -$473.10 K(+58.0%) | -$2.41 M(-6.0%) |
| Oct 2000 | - | -$299.40 K(-59.3%) | -$2.56 M(-4.2%) |
| Jul 2000 | -$2.32 M(+339.8%) | -$735.00 K(-18.1%) | -$2.67 M(+29.5%) |
| Apr 2000 | - | -$897.60 K(+43.2%) | -$2.06 M(+31.8%) |
| Jan 2000 | - | -$626.80 K(+52.4%) | -$1.56 M(+47.8%) |
| Oct 1999 | - | -$411.30 K(+224.1%) | -$1.06 M(+57.6%) |
| Jul 1999 | -$526.90 K(-113.5%) | -$126.90 K(-68.3%) | -$671.90 K(-41.3%) |
| Apr 1999 | - | -$400.00 K(+232.0%) | -$1.15 M(-219.9%) |
| Jan 1999 | - | -$120.50 K(+391.8%) | $955.00 K(-67.5%) |
| Oct 1998 | - | -$24.50 K(-95.9%) | $2.94 M(-26.9%) |
| Jul 1998 | $3.90 M(+387.5%) | -$600.00 K(-135.3%) | $4.02 M(-18.3%) |
| Apr 1998 | - | $1.70 M(-8.7%) | $4.92 M(+39.8%) |
| Jan 1998 | - | $1.86 M(+75.9%) | $3.52 M(+112.3%) |
| Oct 1997 | - | $1.06 M(+252.7%) | $1.66 M(+84.2%) |
| Jul 1997 | $800.00 K(-33.3%) | $300.00 K(0.0%) | $900.00 K(-25.0%) |
| Apr 1997 | - | $300.00 K(>+9900.0%) | $1.20 M(+9.1%) |
| Jan 1997 | - | $0.00(-100.0%) | $1.10 M(-15.4%) |
| Oct 1996 | - | $300.00 K(-50.0%) | $1.30 M(+8.3%) |
| Jul 1996 | $1.20 M | $600.00 K(+200.0%) | $1.20 M(+100.0%) |
| Apr 1996 | - | $200.00 K(0.0%) | $600.00 K(+50.0%) |
| Jan 1996 | - | $200.00 K(0.0%) | $400.00 K(+100.0%) |
| Oct 1995 | - | $200.00 K | $200.00 K |
FAQ
- What is Accelerate Diagnostics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Accelerate Diagnostics?
- What is Accelerate Diagnostics annual EBIT year-on-year change?
- What is Accelerate Diagnostics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Accelerate Diagnostics?
- What is Accelerate Diagnostics quarterly EBIT year-on-year change?
- What is Accelerate Diagnostics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Accelerate Diagnostics?
- What is Accelerate Diagnostics TTM EBIT year-on-year change?
What is Accelerate Diagnostics annual earnings before interest & taxes?
The current annual EBIT of AXDX is -$53.02 M
What is the all time high annual EBIT for Accelerate Diagnostics?
Accelerate Diagnostics all-time high annual earnings before interest & taxes is $3.90 M
What is Accelerate Diagnostics annual EBIT year-on-year change?
Over the past year, AXDX annual earnings before interest & taxes has changed by +$5.77 M (+9.82%)
What is Accelerate Diagnostics quarterly earnings before interest & taxes?
The current quarterly EBIT of AXDX is -$11.05 M
What is the all time high quarterly EBIT for Accelerate Diagnostics?
Accelerate Diagnostics all-time high quarterly earnings before interest & taxes is $3.25 M
What is Accelerate Diagnostics quarterly EBIT year-on-year change?
Over the past year, AXDX quarterly earnings before interest & taxes has changed by $0.00 (0.00%)
What is Accelerate Diagnostics TTM earnings before interest & taxes?
The current TTM EBIT of AXDX is -$42.13 M
What is the all time high TTM EBIT for Accelerate Diagnostics?
Accelerate Diagnostics all-time high TTM earnings before interest & taxes is $4.92 M
What is Accelerate Diagnostics TTM EBIT year-on-year change?
Over the past year, AXDX TTM earnings before interest & taxes has changed by $0.00 (0.00%)